Merck & Company Inc (MRK)vsSensus Healthcare Inc (SRTS)
MRK
Merck & Company Inc
$145.97
+0.52%
HEALTHCARE · Cap: $350.19B
SRTS
Sensus Healthcare Inc
$2.77
0.00%
HEALTHCARE · Cap: $49.88M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 380142% more annual revenue ($66.57B vs $17.51M). MRK leads profitability with a 4.8% profit margin vs -88.4%. MRK earns a higher WallStSmart Score of 36/100 (F).
MRK
Hold36
out of 100
Grade: F
SRTS
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-74.3%
Fair Value
$83.44
Current Price
$145.97
$62.53 premium
Margin of Safety
-70.6%
Fair Value
$2.79
Current Price
$2.77
$0.02 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Reasonable price relative to book value
Earnings expanding 433.3% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
Trading at 8.6x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Smaller company, higher risk/reward
Weak financial health signals
ROE of -17.1% — below average capital efficiency
Revenue declined 68.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : SRTS
The strongest argument for SRTS centers on Price/Book, EPS Growth, Debt/Equity.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 112.7x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : SRTS
The primary concerns for SRTS are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
MRK profiles as a value stock while SRTS is a turnaround play — different risk/reward profiles.
SRTS carries more volatility with a beta of 1.14 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (36/100 vs 33/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Sensus Healthcare Inc
HEALTHCARE · MEDICAL DEVICES · USA
Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton, Florida.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?